---
schema_version: "secwatch.filing_event.v1"
accession: "0001384101-21-000118"
form_type: "8-K"
ticker: "VCYT"
cik: "0001384101"
company_name: "VERACYTE, INC."
filed_at: "2021-07-12T23:59:59+00:00"
generated_at: "2026-06-30T06:01:39.333725+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Veracyte appoints Rebecca Chambers as CFO effective July 19, 2021

## Summary
- Rebecca Chambers, 43, appointed CFO effective July 19, 2021; previously CFO of Outset Medical.
- Jane Alley resigns as acting CFO (same date) but remains VP, Corporate Controller and PAO.
- Chambers gets $450K salary, $100K sign-on bonus, 67,000 stock options, 34,000 RSUs, and up to 13,600 performance-based RSUs.
- Severance: 50% base salary for non-CIC termination; 150% plus full equity vesting for change-of-control termination.

## SEC filing metadata
- accession: 0001384101-21-000118
- form_type: 8-K
- ticker: VCYT
- cik: 0001384101
- company_name: VERACYTE, INC.
- filed_at: 2021-07-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1384101/000138410121000118/0001384101-21-000118-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1384101/000138410121000118/vcyt-20210712.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001384101-21-000118
- JSON: https://secwatch.observer/filing/0001384101-21-000118.json
- Plain text: https://secwatch.observer/filing/0001384101-21-000118.txt

## Key facts
- Executive change
  Jane Alley departed as Acting Chief Financial Officer at VERACYTE, INC..
  - Action: resigning
  - Role: Acting Chief Financial Officer
  source text: Jane Alley, Acting Chief Financial Officer, would be resigning from her position as Acting Chief Financial Officer, effective as of July 19, 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/1384101/000138410121000118/0001384101-21-000118-index.htm
- Executive change
  Rebecca Chambers was appointed as Chief Financial Officer at VERACYTE, INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On July 12, 2021, Veracyte, Inc. (the “Company”) announced that it appointed Rebecca Chambers, 43, as Chief Financial Officer, effective as of July 19, 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/1384101/000138410121000118/0001384101-21-000118-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.